Ixempra (Ixapebilone) – New Cancer Therapy

Print-Icon
Print

Ixabepilone is a microtubule inhibitor that stops cells separating during the G2 phase of the cell cycling.
 
«Back

  • Structure of the breast and mammary gland
  • The most common cancers diagnosed in women in the UK
  • Tumour cells spread from the primary site
  • advanced breast cancer sites
  • Tumour cells develop resistance to chemotherapeutic agents
  • Microtubule inhibitor that stops cells separating during the G2 phase


| 1 | 2 | 3 | 4 | 5 | 6 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development